FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer
Titel:
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer
Auteur:
Loupakis, F. Cremolini, C. Salvatore, L. Masi, G. Sensi, E. Schirripa, M. Michelucci, A. Pfanner, E. Brunetti, I. Lupi, C. Antoniotti, C. Bergamo, F. Lonardi, S. Zagonel, V. Simi, P. Fontanini, G. Falcone, A.